furthermore , patients whose cancers have both estrogen and progestin receptors have a better probability of response than patients whose lesions have only one of the receptors present , although even in such cases the response rate is higher than that seen in patients whose tumors lack both receptors .
C0006826
cancers
C0027651
tumors